Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs GLENMARK LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA GLENMARK LIFE SCIENCES GRANULES INDIA/
GLENMARK LIFE SCIENCES
 
P/E (TTM) x 26.4 18.3 144.1% View Chart
P/BV x 3.7 4.5 83.0% View Chart
Dividend Yield % 0.3 2.7 12.9%  

Financials

 GRANULES INDIA   GLENMARK LIFE SCIENCES
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
GLENMARK LIFE SCIENCES
Mar-23
GRANULES INDIA/
GLENMARK LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs381534 71.4%   
Low Rs227369 61.5%   
Sales per share (Unadj.) Rs186.4176.4 105.7%  
Earnings per share (Unadj.) Rs21.338.1 56.0%  
Cash flow per share (Unadj.) Rs29.041.5 69.7%  
Dividends per share (Unadj.) Rs1.5021.00 7.1%  
Avg Dividend yield %0.54.7 10.6%  
Book value per share (Unadj.) Rs116.4174.0 66.9%  
Shares outstanding (eoy) m242.04122.53 197.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.62.6 63.7%   
Avg P/E ratio x14.211.8 120.3%  
P/CF ratio (eoy) x10.510.9 96.6%  
Price / Book Value ratio x2.62.6 100.7%  
Dividend payout %7.055.1 12.8%   
Avg Mkt Cap Rs m73,61155,321 133.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4,2031,802 233.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,11921,612 208.8%  
Other income Rs m143290 49.3%   
Total revenues Rs m45,26221,902 206.7%   
Gross profit Rs m9,1336,423 142.2%  
Depreciation Rs m1,845421 438.3%   
Interest Rs m5595 10,225.4%   
Profit before tax Rs m6,8726,286 109.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,7061,616 105.5%   
Profit after tax Rs m5,1664,670 110.6%  
Gross profit margin %20.229.7 68.1%  
Effective tax rate %24.825.7 96.5%   
Net profit margin %11.421.6 53.0%  
BALANCE SHEET DATA
Current assets Rs m25,74123,687 108.7%   
Current liabilities Rs m18,13510,228 177.3%   
Net working cap to sales %16.962.3 27.1%  
Current ratio x1.42.3 61.3%  
Inventory Days Days142 895.0%  
Debtors Days Days77136 56.3%  
Net fixed assets Rs m23,2908,518 273.4%   
Share capital Rs m242245 98.8%   
"Free" reserves Rs m27,92721,070 132.5%   
Net worth Rs m28,16921,315 132.2%   
Long term debt Rs m1,4860-   
Total assets Rs m49,03132,205 152.2%  
Interest coverage x13.31,150.2 1.2%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.90.7 137.1%   
Return on assets %11.714.5 80.4%  
Return on equity %18.321.9 83.7%  
Return on capital %25.129.5 84.9%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Exports (fob) Rs m36,526NA-   
Imports (cif) Rs m14,120NA-   
Fx inflow Rs m36,5269,691 376.9%   
Fx outflow Rs m14,1205,001 282.3%   
Net fx Rs m22,4064,689 477.8%   
CASH FLOW
From Operations Rs m7,3873,134 235.7%  
From Investments Rs m-1,914-1,541 124.1%  
From Financial Activity Rs m-4,403-3,876 113.6%  
Net Cashflow Rs m1,068-2,283 -46.8%  

Share Holding

Indian Promoters % 41.6 82.9 50.2%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 28.9 5.3 544.8%  
FIIs % 18.8 4.6 410.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 17.2 338.4%  
Shareholders   190,691 185,531 102.8%  
Pledged promoter(s) holding % 4.1 9.5 43.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs GLENMARK LIFE SCIENCES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs GLENMARK LIFE SCIENCES Share Price Performance

Period GRANULES INDIA GLENMARK LIFE SCIENCES S&P BSE HEALTHCARE
1-Day 0.03% 0.01% 1.18%
1-Month -6.51% -11.59% -0.75%
1-Year 58.65% 106.25% 61.82%
3-Year CAGR 11.62% 1.19% 18.16%
5-Year CAGR 29.84% 0.71% 19.79%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the GLENMARK LIFE SCIENCES share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of GLENMARK LIFE SCIENCES the stake stands at 82.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of GLENMARK LIFE SCIENCES.

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

GLENMARK LIFE SCIENCES paid Rs 21.0, and its dividend payout ratio stood at 55.1%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of GLENMARK LIFE SCIENCES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.